home · filing · 0001213900-24-004855
8-K
filed January 19, 2024, 6:59 PM ET
ticker ONCO
CIK 0001782107
other material
confidence high
sentiment neutral
materiality 0.30
Onconetix finalizes separation with former CBO; consulting fee $27k/month for 3 months
Onconetix, Inc.
Erin Henderson resigned as Chief Business Officer effective Dec 21, 2023; separation and consulting agreements signed Jan 17, 2024.
Consulting agreement with her firm Aetos Group; monthly fee ~$27,083 until April 25, 2024.
Separation agreement includes mutual releases and non-disparagement; consulting fee is additional consideration.
Previous employment agreement restrictive covenants survive termination.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Departed
Erin Henderson
Chief Business Officer
Effective 2023-12-21
Filed January 19, 2024, 6:59 PM ET
Erin Henderson resigned as Chief Business Officer of Onconetix, Inc. (the “Company”), effective as of December 21, 2023.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Erin Henderson resigned as Chief Business Officer at Onconetix, Inc..
Action resigned
Role Chief Business Officer
Exact text from the filing
Erin Henderson resigned as Chief Business Officer of Onconetix, Inc. (the “Company”), effective as of December 21, 2023.
View on SEC.gov
Source: SEC EDGAR
accession 0001213900-24-004855
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.